Award

BPA Call #36C25527N0003

BPA Call for Advanced PCR Molecular Systems at VA Medical Centers

Buyer

Department of Veterans Affairs

Award Amount

$183,970.80

Ceiling

$183,970.80

Awarded

November 03, 2026

Period of Performance

Nov 03, 2026 – Nov 02, 2027

Identifier

36C25527N0003

NAICS

339112

This award represents a BPA (Blanket Purchase Agreement) call option, renewing provision of PCR molecular testing systems to the Veterans Affairs Medical Centers in Columbia and Kansas City. The contract recipient, Cepheid, is a prominent American molecular diagnostics company specializing in cutting-edge testing technologies crucial for rapid and precise disease detection. The contract supports the Department of Veterans Affairs by supplying advanced PCR molecular diagnostic equipment, enabling enhanced healthcare services for veterans at these facilities. The scope includes delivery of state-of-the-art molecular systems under a competitive BPA established through a comprehensive acquisition strategy. This option marks the fourth year of an ongoing multi-year agreement, demonstrating sustained investment in modern diagnostic capabilities at VA medical centers. The contract is competitively awarded under the parent Blanket Purchase Agreement initiated in 2022, ensuring continuity and adherence to federal acquisition regulations. The one-year performance period underscores the VA's commitment to maintaining up-to-date diagnostic tools for improved veteran care.

Description

PCR MOLECULAR SYSTEM - COLUMBIA AND KC VAMCS - OPTION YEAR FOUR

View original record